Transcranial direct current stimulation (tDCS) in cognitively symptomatic older adults

tDCS offers an inexpensive, portable, well‐tolerated, and safe approach to neuromodulation. These benefits led to a rapid increase in its use as a potential treatment for those with Alzheimer’s disease and related dementias (ADRD), yet were accompanied by a number of methodological gaps that limit its current translational potential. This session will introduce and evaluate several such methodological factors including potential mechanisms of action, dose‐response relationships, session frequency and duration, and individual factors that may account for variable treatment response.